Form 4: Director Carol Lindstrom Receives Genpact RSU Grant

Genpact Limited director Carol Lindstrom was granted 6,521 restricted share units as part of the company's incentive compensation plan.

Summary

• Director Carol Lindstrom acquired 6,521 restricted share units (RSUs) on April 23, 2026.
• The grant was issued under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
• Following this transaction, the director's total beneficial ownership of common shares increased to 27,706.
• The RSUs are subject to continued service requirements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is contingent upon the director's continued service to the company.

Future Outlook

The RSUs are scheduled to vest on December 31, 2026, and will be settled in common shares on December 31, 2027, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to non-executive directors are standard corporate governance practice to ensure board members maintain a vested interest in the company's long-term performance.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices for large-cap IT and business process management firms.

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation structure.

Next Steps

• Vesting of RSUs on December 31, 2026.
• Settlement of RSUs into common shares on December 31, 2027.

Key Dates

Keywords

Genpact, Form 4, Insider Trading, Director Compensation, Equity Incentive Plan